LeMaitre Vascular Inc (NASDAQ:LMAT) — Market Cap & Net Worth
Market Cap & Net Worth: LeMaitre Vascular Inc (LMAT)
LeMaitre Vascular Inc (NASDAQ:LMAT) has a market capitalization of $1.82 Billion ($1.82 Billion) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6539 globally and #2058 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LeMaitre Vascular Inc's stock price $79.47 by its total outstanding shares 22850739 (22.85 Million). Also see LMAT total asset value for a full breakdown of the balance sheet.
LeMaitre Vascular Inc Market Cap History: 2015 to 2026
LeMaitre Vascular Inc's market capitalization history from 2015 to 2026. Data shows growth from $361.16 Million to $1.82 Billion (19.15% CAGR). Also see how efficiently does LeMaitre Vascular Inc generate cash for how efficiently the company converts equity into cash flow.
Index Memberships
LeMaitre Vascular Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.07% | #187 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #737 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.61 Trillion | 0.15% | #346 of 602 |
Weight: LeMaitre Vascular Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LeMaitre Vascular Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LeMaitre Vascular Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest LeMaitre Vascular Inc stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
7.42x
LeMaitre Vascular Inc's market cap is 7.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
32.10x
LeMaitre Vascular Inc's market cap is 32.10 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $536.19 Million | $89.15 Million | $10.59 Million | 6.01x | 50.63x |
| 2017 | $678.69 Million | $100.87 Million | $17.18 Million | 6.73x | 39.51x |
| 2018 | $508.14 Million | $105.57 Million | $22.94 Million | 4.81x | 22.15x |
| 2019 | $781.34 Million | $117.23 Million | $17.93 Million | 6.66x | 43.57x |
| 2020 | $891.45 Million | $129.37 Million | $21.22 Million | 6.89x | 42.01x |
| 2021 | $1.12 Billion | $154.42 Million | $26.91 Million | 7.22x | 41.45x |
| 2022 | $1.03 Billion | $161.65 Million | $20.64 Million | 6.39x | 50.04x |
| 2023 | $1.29 Billion | $193.48 Million | $30.11 Million | 6.65x | 42.74x |
| 2024 | $2.11 Billion | $219.86 Million | $44.04 Million | 9.58x | 47.81x |
| 2025 | $1.85 Billion | $249.60 Million | $57.73 Million | 7.42x | 32.10x |
Competitor Companies of LMAT by Market Capitalization
Companies near LeMaitre Vascular Inc in the global market cap rankings as of September 18, 2026. Review LeMaitre Vascular Inc (LMAT) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to LeMaitre Vascular Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #177 globally with a market cap of $135.72 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #363 globally with a market cap of $76.57 Billion USD ( €65.50 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #424 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #543 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Intuitive Surgical Inc | NASDAQ:ISRG | $135.72 Billion | $383.54 |
| #363 | EssilorLuxottica S. A. | PA:EL | $76.57 Billion | €141.45 |
| #424 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €70.50 |
| #543 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
LeMaitre Vascular Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, LeMaitre Vascular Inc's market cap moved from $361.16 Million to $ 1.82 Billion, with a yearly change of 19.15%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.82 Billion | -2.01% |
| 2025 | $1.85 Billion | -11.98% |
| 2024 | $2.11 Billion | +63.63% |
| 2023 | $1.29 Billion | +24.60% |
| 2022 | $1.03 Billion | -7.40% |
| 2021 | $1.12 Billion | +25.10% |
| 2020 | $891.45 Million | +14.09% |
| 2019 | $781.34 Million | +53.77% |
| 2018 | $508.14 Million | -25.13% |
| 2017 | $678.69 Million | +26.58% |
| 2016 | $536.19 Million | +48.46% |
| 2015 | $361.16 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of LeMaitre Vascular Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.82 Billion USD |
| MoneyControl | $1.82 Billion USD |
| MarketWatch | $1.82 Billion USD |
| marketcap.company | $1.82 Billion USD |
| Reuters | $1.82 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more